BioScience Health Innovations, Inc. (BHIC)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Jul 18, 2025

BHIC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
0.570.09-0.25-0.17-0.01
Stock-Based Compensation
---00.01
Change in Accounts Receivable
-0.07-0.06-0.03-0.01-
Change in Inventory
-0.18-0.02-0.03-0.01-
Change in Accounts Payable
0.010-0.01--
Change in Unearned Revenue
0.050.020--
Change in Other Net Operating Assets
0.02-0000
Operating Cash Flow
0.40.02-0.31-0.180
Sale (Purchase) of Intangibles
-0.06-0.03---
Investing Cash Flow
-0.06-0.03---
Short-Term Debt Issued
-0.960.610.18-
Total Debt Issued
1.320.960.610.18-
Short-Term Debt Repaid
--1.07-0.57-0.13-
Total Debt Repaid
-1.31-1.07-0.57-0.13-
Net Debt Issued (Repaid)
0.01-0.110.040.04-
Issuance of Common Stock
0.580.760.270.15-
Other Financing Activities
--0.01--
Financing Cash Flow
0.590.650.320.19-
Net Cash Flow
0.940.640.010.010
Levered Free Cash Flow
0.13-0.06-0.2-0.08-
Unlevered Free Cash Flow
0.13-0.06-0.2-0.08-
Change in Net Working Capital
0.170.090.040.02-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.